Clinical Trial Update: To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether GLP-1 can improve glucose homeostasis in humans following Roux-en-Y gastric bypass surgery; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Bypass, Gastric, Roux-en-Y Gastric Bypass | Phase 1 | Status: COMPLETED